Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian
Source: SeekingAlpha
2026-06-04 11:22:43 ET
More on Pfizer, GSK, etc.
- GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript
- Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript
- Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data Transcript
- Pfizer in pact with Chai Discovery to use AI platform in drug development
- Moderna, Merck release promising data on mRNA cancer vaccine
Read the full article on Seeking Alpha
For further details see:
Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian
Merck & Company Inc.
NASDAQ: MRK
MRK Trading
-2.39% G/L:
$124.45 Last:
4,556,035 Volume:
$127.285 Open:
MRK Latest News
July 01, 2026 06:45:00 am
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
$291,612,827,755
2,457,202,311
0.02%
2165
N/A
Pharmaceuticals
Healthcare
US
Rahway
